CH405281A - Verfahren zur Herstellung basischer Verbindungen - Google Patents

Verfahren zur Herstellung basischer Verbindungen

Info

Publication number: CH405281A
Authority: CH; Switzerland
Prior art keywords: acid; formula; bis; hydrogen; phenyl
Prior art date: 1961-11-24

Application number

CH1365261A

Other languages

German (de)

English (en)

Inventor

Rudolf Dr Hirt

Original Assignee

Wander Ag Dr A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1961-11-24

Filing date

1961-11-24

Publication date

1966-01-15

1961-11-24 Application filed by Wander Ag Dr A filed Critical Wander Ag Dr A

1961-11-24 Priority to CH1365261A priority Critical patent/CH405281A/de

1962-11-15 Priority to DE19621518191 priority patent/DE1518191A1/de

1962-11-19 Priority to AT907762A priority patent/AT240837B/de

1962-11-20 Priority to GB43880/62A priority patent/GB1016653A/en

1962-11-20 Priority to FI2081/62A priority patent/FI40286B/fi

1962-11-23 Priority to ES282740A priority patent/ES282740A1/es

1964-12-30 Priority to OA51193A priority patent/OA01088A/fr

1966-01-15 Publication of CH405281A publication Critical patent/CH405281A/de

Links

238000000034 method Methods 0.000 title claims description 14
150000007514 bases Chemical class 0.000 title claims description 7
238000002360 preparation method Methods 0.000 title claims description 6
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 15
150000003839 salts Chemical class 0.000 claims description 13
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 11
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 10
239000002253 acid Substances 0.000 claims description 9
125000000217 alkyl group Chemical group 0.000 claims description 9
125000004432 carbon atom Chemical group C* 0.000 claims description 9
150000001875 compounds Chemical class 0.000 claims description 8
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
229910052739 hydrogen Inorganic materials 0.000 claims description 6
239000001257 hydrogen Substances 0.000 claims description 6
229910021529 ammonia Inorganic materials 0.000 claims description 5
125000003545 alkoxy group Chemical group 0.000 claims description 4
125000005843 halogen group Chemical group 0.000 claims description 4
239000004310 lactic acid Substances 0.000 claims description 4
235000014655 lactic acid Nutrition 0.000 claims description 4
150000001412 amines Chemical class 0.000 claims description 3
KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims description 2
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 2
239000005977 Ethylene Substances 0.000 claims description 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
125000003342 alkenyl group Chemical group 0.000 claims description 2
BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 2
125000002768 hydroxyalkyl group Chemical group 0.000 claims description 2
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
150000003141 primary amines Chemical class 0.000 claims description 2
125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 2
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
230000001419 dependent effect Effects 0.000 claims 1
239000000174 gluconic acid Substances 0.000 claims 1
235000013922 glutamic acid Nutrition 0.000 claims 1
239000004220 glutamic acid Substances 0.000 claims 1
-1 [p- (N', N" -dimethyl-amidino) -phenyl] -terephthalimide chloride Chemical compound 0.000 description 26
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
239000000243 solution Substances 0.000 description 15
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 13
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
238000002844 melting Methods 0.000 description 9
230000008018 melting Effects 0.000 description 9
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 8
238000000354 decomposition reaction Methods 0.000 description 7
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
239000007787 solid Substances 0.000 description 6
239000002585 base Substances 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
239000000706 filtrate Substances 0.000 description 4
239000011541 reaction mixture Substances 0.000 description 4
206010028980 Neoplasm Diseases 0.000 description 3
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
229960000583 acetic acid Drugs 0.000 description 3
239000004480 active ingredient Substances 0.000 description 3
239000007864 aqueous solution Substances 0.000 description 3
201000011510 cancer Diseases 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
238000001914 filtration Methods 0.000 description 3
239000000047 product Substances 0.000 description 3
230000004083 survival effect Effects 0.000 description 3
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical class OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
PNIUHARIZYISMH-UHFFFAOYSA-N O=C(C1=CC2=CC=C1)NC2=O.Cl Chemical compound O=C(C1=CC2=CC=C1)NC2=O.Cl PNIUHARIZYISMH-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
235000011054 acetic acid Nutrition 0.000 description 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
201000008827 tuberculosis Diseases 0.000 description 2
NAOLWIGVYRIGTP-UHFFFAOYSA-N 1,3,5-trihydroxyanthracene-9,10-dione Chemical class C1=CC(O)=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1 NAOLWIGVYRIGTP-UHFFFAOYSA-N 0.000 description 1
YBWWSEJGBHDPHA-UHFFFAOYSA-N 1-n',4-n'-bis[4-(n'-methylcarbamimidoyl)phenyl]benzene-1,4-dicarboximidamide;tetrahydrochloride Chemical compound Cl.Cl.Cl.Cl.C1=CC(C(N)=NC)=CC=C1N=C(N)C1=CC=C(C(N)=NC=2C=CC(=CC=2)C(N)=NC)C=C1 YBWWSEJGBHDPHA-UHFFFAOYSA-N 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
201000009030 Carcinoma Diseases 0.000 description 1
ABSLZVQHYCSIIY-UHFFFAOYSA-N Cl.Cl.Cl.Cl.C(C)N=C(N)C1=CC=C(C=C1)NC(C1=CC=C(C(=N)N)C=C1)=NC1=CC=C(C=C1)C(N)=NCC Chemical compound Cl.Cl.Cl.Cl.C(C)N=C(N)C1=CC=C(C=C1)NC(C1=CC=C(C(=N)N)C=C1)=NC1=CC=C(C=C1)C(N)=NCC ABSLZVQHYCSIIY-UHFFFAOYSA-N 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
DSLZVSRJTYRBFB-UHFFFAOYSA-N Galactaric acid Chemical class OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
241000187479 Mycobacterium tuberculosis Species 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
206010039491 Sarcoma Diseases 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
150000008044 alkali metal hydroxides Chemical class 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
230000000719 anti-leukaemic effect Effects 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
239000000969 carrier Substances 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
230000000973 chemotherapeutic effect Effects 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
125000001309 chloro group Chemical group Cl* 0.000 description 1
229940127089 cytotoxic agent Drugs 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
238000005187 foaming Methods 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
239000012458 free base Substances 0.000 description 1
DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical class OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 description 1
239000012362 glacial acetic acid Substances 0.000 description 1
230000009422 growth inhibiting effect Effects 0.000 description 1
229940093915 gynecological organic acid Drugs 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
239000013067 intermediate product Substances 0.000 description 1
230000003902 lesion Effects 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
238000002156 mixing Methods 0.000 description 1
239000000203 mixture Substances 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
239000002674 ointment Substances 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
235000006408 oxalic acid Nutrition 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
235000011007 phosphoric acid Nutrition 0.000 description 1
239000000843 powder Substances 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
230000001376 precipitating effect Effects 0.000 description 1
235000019260 propionic acid Nutrition 0.000 description 1
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
239000000376 reactant Substances 0.000 description 1
229960004889 salicylic acid Drugs 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
239000002904 solvent Substances 0.000 description 1
239000007858 starting material Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
230000001549 tubercolostatic effect Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

CH1365261A 1961-11-24 1961-11-24 Verfahren zur Herstellung basischer Verbindungen CH405281A (de)

Priority Applications (7)

Application Number	Priority Date	Filing Date	Title
CH1365261A CH405281A (de)	1961-11-24	1961-11-24	Verfahren zur Herstellung basischer Verbindungen
DE19621518191 DE1518191A1 (de)	1961-11-24	1962-11-15	Phthalamidine
AT907762A AT240837B (de)	1961-11-24	1962-11-19	Verfahren zur Herstellung neuer Phthalamidine und ihrer Salze
GB43880/62A GB1016653A (en)	1961-11-24	1962-11-20	Polybasic compounds and process for their production
FI2081/62A FI40286B (fr)	1961-11-24	1962-11-20
ES282740A ES282740A1 (es)	1961-11-24	1962-11-23	Procedimiento para la producción de compuestos polibásicos
OA51193A OA01088A (fr)	1961-11-24	1964-12-30	Procédé de préparation de composés polybasiques.

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CH1365261A CH405281A (de)	1961-11-24	1961-11-24	Verfahren zur Herstellung basischer Verbindungen

Publications (1)

Publication Number	Publication Date
CH405281A true CH405281A (de)	1966-01-15

Family

ID=4394198

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CH1365261A CH405281A (de)	1961-11-24	1961-11-24	Verfahren zur Herstellung basischer Verbindungen

Country Status (7)

Country	Link
AT (1)	AT240837B (fr)
CH (1)	CH405281A (fr)
DE (1)	DE1518191A1 (fr)
ES (1)	ES282740A1 (fr)
FI (1)	FI40286B (fr)
GB (1)	GB1016653A (fr)
OA (1)	OA01088A (fr)

1961
- 1961-11-24 CH CH1365261A patent/CH405281A/de unknown
1962
- 1962-11-15 DE DE19621518191 patent/DE1518191A1/de active Pending
- 1962-11-19 AT AT907762A patent/AT240837B/de active
- 1962-11-20 FI FI2081/62A patent/FI40286B/fi active
- 1962-11-20 GB GB43880/62A patent/GB1016653A/en not_active Expired
- 1962-11-23 ES ES282740A patent/ES282740A1/es not_active Expired
1964
- 1964-12-30 OA OA51193A patent/OA01088A/fr unknown

Also Published As

Publication number	Publication date
OA01088A (fr)	1968-08-07
GB1016653A (en)	1966-01-12
AT240837B (de)	1965-06-25
DE1518191A1 (de)	1969-07-31
FI40286B (fr)	1968-09-02
ES282740A1 (es)	1963-06-01

Publication	Publication Date	Title
CH479557A (de)	1969-10-15	Verfahren zur Herstellung neuer mehrbasischer Verbindungen
DE1906527C3 (de)	1981-07-02	Thioninderivate, Verfahren zu deren Herstellung und pharmazeutische Präparate, welche diese enthalten
DE2914294A1 (de)	1979-10-25	Verfahren zur herstellung von verbindungen mit phosphor-kohlenstoff- stickstoff-bindung
DE2232988A1 (de)	1973-01-25	Filarizide und trypanocide phenylarsendithioverbindungen
DE1545607A1 (de)	1969-12-04	Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
DE2203653B2 (de)	1974-12-19	3-Carbamoyloxymethyl-7-(2-thienylacetamido)-3-cephem-4-carbonsäure und deren Salze, Verfahren zur Herstellung dieser Verbindungen und solche Verbindungen enthaltende Arzneimittel
CH525898A (de)	1972-07-31	Verfahren zur Herstellung mehrbasischer Verbindungen
CH405281A (de)	1966-01-15	Verfahren zur Herstellung basischer Verbindungen
DE2166270C3 (de)	1975-10-09	Nicotinoylaminoäthansulfonyl-2amino-thiazol
DE1470421A1 (de)	1969-06-26	Mehrbasische Verbindungen
CH405282A (de)	1966-01-15	Verfahren zur Herstellung basischer Verbindungen
DE3024304C2 (fr)	1991-10-31
DE2536951B2 (de)	1978-06-01	Triazapentadiene, Verfahren zu ihrer Herstellung und diese enthaltende insektizide Mittel
DE1545712A1 (de)	1969-06-12	Chelat-Verbindungen und Verfahren zu ihrer Herstellung
AT256866B (de)	1967-09-11	Verfahren zur Herstellung neuer mehrbasischer Verbindungen
DE855121C (de)	1952-11-10	Verfahren zur Herstellung von Azomethinen und Komplexsalzen derselben
DE1169948B (de)	1964-05-14	Verfahren zur Herstellung von antibakteriell wirksamen N, N'-Alkylen-1, 1'-alkylen-bis-(4-aminochinolinium-halogeniden)
DE1241437B (de)	1967-06-01	Verfahren zur Herstellung von Biguanid-guanylhydrazonverbindungen
DE1134071C2 (de)	1975-02-20	Verfahren zur herstellung von neuen derivaten der tetracyclin-antibiotica
AT326101B (de)	1975-11-25	Verfahren zur herstellung von neuen substituierten formylazapentadiennitrilen sowie von deren säureadditionssalzen
DE1670938C3 (de)	1979-02-08	Am Amidin-Stickstoff substituierte 2-Methyl-3-amidino-chinoxalin-di-N-oxide -(1.4)
AT226713B (de)	1963-04-10	Verfahren zur Herstellung von neuen Piperazinderivaten
DE822993C (de)	1951-11-29	Verfahren zur Herstellung asymmetrischer Arsenobenzolverbindungen
DE1670162C3 (de)	1979-02-22	Verfahren zur Herstellung von 2-substituierten Phenylamino-13-diazacycloalkenen-(2) und dessen Säureadditionssalzen
DE1801305A1 (de)	1969-05-14	Verfahren zur Herstellung von 7-Chlor-2,3-dihydro-1-methyl-5-o-trifluormethylphenyl-1 H-1,4-benzodiazepin